Effect of Ultrasound Guided Embryo Transfer on Pregnancy Rates (ET)

March 25, 2013 updated by: Noha Rabei, Ain Shams Maternity Hospital
To assess the effect of transabdominal ultrasound guided embryo transfer on the pregnancy rates versus clinical touch technique

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

A total of 90 patients undergoing treatment with ICSI were divided into 2 groups: group 1 (45 patients), had ultrasound guided embryo transfer and group 2 (45 patients), underwent embryo transfer using the clinical touch technique

Study Type

Interventional

Enrollment (Actual)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • Cairo, Egypt
        • IVF Unit, Ain Shams Maternity Hospital, Ain Shams University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 39 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Age (20-39)
  • Male factor infertility
  • Ovarian factor infertility
  • Unexplained infertility

Exclusion Criteria:

  • Tubal factor infertility
  • Endometriosis
  • FSH > 16 iu/l on cycle day 3
  • Less than 2 embryos grade A
  • Difficult embryo transfer

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Ultrasound guided embryo transfer
GnRh, HMG, HCG, Progesterone 45 patients had ultrasound guided embryo transfer during ICSI
Drug: GnRh, HMG, HCG, Progesterone
GnRh analogue (0.05 mg/day), HMG (150-300 iu/day), HCG (5000 iu/day), Progesterone (100 mg/day)
PLACEBO_COMPARATOR: clinical touch technique
GnRh, HMG, HCG, Progesterone 45 patients had embryo transfer using clinical touch technique during ICSI
Drug: GnRh, HMG, HCG, Progesterone
GnRh analogue (0.05 mg/day), HMG (150-300 iu/day), HCG (5000 iu/day), Progesterone (100 mg/day)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
To assess clinical pregnancy rates after using ultrasound guided embryo transfer
Time Frame: After December, 2012
After December, 2012

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Ain Shams Maternity Hospital

Investigators

  • Study Director: Ahmed R Ammar, MD, Ain Shams University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2009

Primary Completion (ACTUAL)

August 1, 2011

Study Completion (ACTUAL)

August 1, 2011

Study Registration Dates

First Submitted

March 12, 2013

First Submitted That Met QC Criteria

March 12, 2013

First Posted (ESTIMATE)

March 13, 2013

Study Record Updates

Last Update Posted (ESTIMATE)

March 26, 2013

Last Update Submitted That Met QC Criteria

March 25, 2013

Last Verified

March 1, 2013

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • noharabei-1

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Infertility

Clinical Trials on GnRh, HMG, HCG, Progesterone

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ukraine

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe